ArticleCardio-oncology (London, England)2023

Cardiovascular adverse events of antineoplastic monoclonal antibodies among cancer patients: real-world evidence from a tertiary healthcare system.

Abdulrazaq S Al-Jazairi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.